Delisted from NYSE in Apr 2024
SFE - Safeguard Scientifics, Inc.
NYSE
->
Financial Services
->
Asset Management
Radnor,
United States
Type: Equity
SFE price evolution
SFE
| (in millions $) | 30 Sep 2023 | 30 Jul 2023 | 31 Mar 2023 | 31 Jan 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $15.69 | $14.27 | $11.03 | $13.36 |
| Short term investments | $0.84 | $7.76 | $5.96 | |
| Net receivables | ||||
| Inventory | ||||
| Total current assets | $16.28 | $16.73 | $20.14 | $21.42 |
| Long term investments | $14.84 | $12.97 | $11.99 | $14.54 |
| Property, plant & equipment | $1.05 | $1.14 | $1.22 | $1.29 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $16.15 | $14.36 | $13.59 | $16.27 |
| Total investments | $14.84 | $13.81 | $19.75 | $20.5 |
| Total assets | $32.43 | $31.08 | $33.73 | $37.69 |
| Current liabilities | ||||
| Accounts payable | $0.1 | $0.07 | $0.07 | $0.02 |
| Deferred revenue | ||||
| Short long term debt | $0.47 | $0.46 | $0.44 | $0.43 |
| Total current liabilities | $1.56 | $1.26 | $1.15 | $1.82 |
| Long term debt | $0.89 | $1.01 | $1.13 | $1.25 |
| Total noncurrent liabilities | $0.94 | $1.06 | $1.18 | $1.3 |
| Total debt | $1.36 | $1.47 | $1.58 | $1.68 |
| Total liabilities | $2.5 | $2.32 | $2.33 | $3.12 |
| Shareholders' equity | ||||
| Retained earnings | -$729.31 | -$730.24 | -$727.38 | -$723.9 |
| Other shareholder equity | -$0.03 | -$0.03 | -$0.03 | -$0.03 |
| Total shareholder equity | $29.93 | $28.76 | $31.39 | $34.58 |
| (in millions $) | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $13.36 | $24.76 | $15.6 | $25.05 |
| Short term investments | $5.96 | |||
| Net receivables | ||||
| Inventory | ||||
| Total current assets | $21.42 | $30.28 | $16.06 | $26.35 |
| Long term investments | $14.54 | $21.97 | $50.4 | $77.13 |
| Property, plant & equipment | $1.29 | $1.56 | $1.79 | $2.1 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $16.27 | $23.75 | $52.97 | $81.23 |
| Total investments | $20.5 | $21.97 | $50.4 | $77.13 |
| Total assets | $37.69 | $54.03 | $69.03 | $107.58 |
| Current liabilities | ||||
| Accounts payable | $0.02 | $0.04 | $0.06 | $0.04 |
| Deferred revenue | ||||
| Short long term debt | $0.43 | $0.38 | $0.33 | $0.4 |
| Total current liabilities | $1.82 | $1.73 | $3.47 | $2.43 |
| Long term debt | $1.25 | $1.68 | $2.05 | $2.38 |
| Total noncurrent liabilities | $1.3 | $1.73 | $2.69 | $3.41 |
| Total debt | $1.68 | $2.05 | $2.38 | $2.78 |
| Total liabilities | $3.12 | $3.46 | $6.16 | $5.84 |
| Shareholders' equity | ||||
| Retained earnings | -$723.9 | -$709.63 | -$736.64 | -$697.22 |
| Other shareholder equity | $34.58 | -$0.03 | -$0.03 | -$0.03 |
| Total shareholder equity | $34.58 | $50.57 | $62.88 | $101.74 |
| (in millions $) | 30 Sep 2023 | 30 Jul 2023 | 31 Mar 2023 | 31 Dec 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $1.31 | $1.19 | $1.03 | |
| Total operating expenses | $1.31 | $1.19 | $1.03 | |
| Operating income | -$1.31 | -$1.19 | -$1.03 | |
| Income from continuing operations | ||||
| EBIT | $0.93 | -$3.48 | -$4.87 | |
| Income tax expense | ||||
| Interest expense | ||||
| Net income | ||||
| Net income | $0.93 | -$3.48 | -$4.87 | |
| Income (for common shares) | $0.93 | -$3.48 | -$4.87 | |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $4.78 | $7.15 | $9.47 | $9.98 |
| Total operating expenses | $4.78 | $7.15 | $9.47 | $9.98 |
| Operating income | -$4.78 | -$7.15 | -$9.47 | -$9.98 |
| Income from continuing operations | ||||
| EBIT | -$14.26 | $27 | -$37.62 | $68.58 |
| Income tax expense | ||||
| Interest expense | $14.02 | |||
| Net income | ||||
| Net income | -$14.26 | $27 | -$37.62 | $54.56 |
| Income (for common shares) | -$14.26 | $27 | -$37.62 | $54.56 |
| (in millions $) | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 | 31 Dec 2022 |
|---|---|---|---|---|
| Net income | $0.93 | -$2.86 | -$3.48 | -$4.87 |
| Operating activities | ||||
| Depreciation | $0.27 | |||
| Business acquisitions & disposals | $1.01 | -$2.56 | $0.6 | -$0.28 |
| Stock-based compensation | $1.45 | |||
| Total cash flows from operations | -$0.43 | -$1.13 | -$0.93 | -$0.6 |
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | $0.85 | $6.96 | -$1.69 | $0.08 |
| Total cash flows from investing | $1.86 | $4.4 | -$1.09 | -$0.2 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$0.07 | -$0.88 | ||
| Net borrowings | ||||
| Total cash flows from financing | -$0.02 | -$0.03 | -$0.3 | -$0.91 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $1.41 | $3.24 | -$2.32 | -$1.7 |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Net income | -$14.26 | $27 | -$37.62 | $54.56 |
| Operating activities | ||||
| Depreciation | $0.27 | $0.23 | $0.31 | $1.07 |
| Business acquisitions & disposals | $1.21 | $58.11 | -$1.27 | $87.61 |
| Stock-based compensation | $1.45 | $1.78 | $0.96 | $1.24 |
| Total cash flows from operations | -$3.26 | -$8.15 | -$8.14 | -$19.97 |
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | -$5.87 | $38.7 | ||
| Total cash flows from investing | -$4.66 | $58.11 | -$1.27 | $126.3 |
| Financing activities | ||||
| Dividends paid | -$20.68 | |||
| Sale and purchase of stock | -$2.94 | -$40.66 | ||
| Net borrowings | -$68.57 | |||
| Total cash flows from financing | -$3.49 | -$40.8 | -$0.04 | -$89.48 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$11.41 | $9.16 | -$9.45 | $16.85 |
News
|
Safeguard Scientifics, Inc. (NYSE:SFE) Q3 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance
5 Nov 2023
|
|
Safeguard Scientifics Inc (SFE) Announces Third Quarter 2023 Financial Results
GuruFocus.com via Yahoo Finance
2 Nov 2023
|
|
10 Stocks That Are About To Explode
Insider Monkey via Yahoo Finance
1 Sep 2023
|
|
10 Best Stocks to Buy According to Ron Mass’ Almitas Capital
Insider Monkey via Yahoo Finance
19 Sep 2022
|
|
Top 10 Stock Picks of Eli Samaha’s Madison Avenue Partners
Insider Monkey via Yahoo Finance
25 Nov 2021
|
|
Is AYLA Stock A Buy Here?
Insider Monkey via Yahoo Finance
21 Oct 2021
|
|
Here is What Hedge Funds Think About Avinger Inc (AVGR)
Insider Monkey via Yahoo Finance
9 Jun 2021
|
|
Earnings Scheduled For March 4, 2021
Benzinga via Yahoo Finance
28 Nov 2020
|
|
Is CEIX A Good Stock To Buy Now?
Insider Monkey via Yahoo Finance
20 Oct 2020
|
|
Should I Avoid Esquire Financial Holdings, Inc. (ESQ)?
Insider Monkey via Yahoo Finance
20 Oct 2020
|
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 16.51M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | 0.00 |
| Book/Share | 1.81 |
| Cash/Share | 0.95 |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.09 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 10.41 |
| Quick ratio | 10.41 |